Povsic, T. J., Vavalle, J. P., Aberle, L. H., Zelenkofske, S. L., Mehran, R., Cohen, M. G., … Alexander, J. H. (2011). Use of the REG1 Anticoagulation System During PCI May Improve Bleeding and Ischemic Complications Compared with Heparin: A PCI Substudy from the Phase 2B RADAR Trial. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (Vol. 58, pp. B47–B48). San Francisco, CA: ELSEVIER SCIENCE INC.

Povsic, Thomas Joseph, John P. Vavalle, Laura H. Aberle, Steven L. Zelenkofske, Roxana Mehran, Mauricio G. Cohen, Christopher E. Buller, et al. “Use of the REG1 Anticoagulation System During PCI May Improve Bleeding and Ischemic Complications Compared with Heparin: A PCI Substudy from the Phase 2B RADAR Trial.” In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 58:B47–48. ELSEVIER SCIENCE INC, 2011.

Povsic TJ, Vavalle JP, Aberle LH, Zelenkofske SL, Mehran R, Cohen MG, et al. Use of the REG1 Anticoagulation System During PCI May Improve Bleeding and Ischemic Complications Compared with Heparin: A PCI Substudy from the Phase 2B RADAR Trial. In: JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. ELSEVIER SCIENCE INC; 2011. p. B47–8.

Povsic, Thomas Joseph, et al. “Use of the REG1 Anticoagulation System During PCI May Improve Bleeding and Ischemic Complications Compared with Heparin: A PCI Substudy from the Phase 2B RADAR Trial.” JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, vol. 58, no. 20, ELSEVIER SCIENCE INC, 2011, pp. B47–48.

Povsic TJ, Vavalle JP, Aberle LH, Zelenkofske SL, Mehran R, Cohen MG, Buller CE, Cornel JH, Kasprzak JD, Montalescot G, Fail P, Sarembock IJ, Alexander JH. Use of the REG1 Anticoagulation System During PCI May Improve Bleeding and Ischemic Complications Compared with Heparin: A PCI Substudy from the Phase 2B RADAR Trial. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. ELSEVIER SCIENCE INC; 2011. p. B47–B48.